Trials / Completed
CompletedNCT04945226
A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001
A Randomized, Open-Label, Exploratory, Pharmacokinetic, Sequential Single Ascending Dose Study of IVL3001 Versus Propecia (Finasteride) Tablets in Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Inventage Lab., Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001
Detailed description
A Randomized, Open-Label, Exploratory, Pharmacokinetic, Sequential Single Ascending dose Study of IVL3001 Versus Propecia (Finasteride) Tablets in Healthy Adult Participants
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Finasteride 1mg Tablet | Propecia Tablet 1mg |
| DRUG | IVL3001 | Finasteride long acting injection |
Timeline
- Start date
- 2021-09-21
- Primary completion
- 2022-02-08
- Completion
- 2022-02-08
- First posted
- 2021-06-30
- Last updated
- 2022-03-04
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT04945226. Inclusion in this directory is not an endorsement.